Radiopharm Theranostics earnings release, September 11, 2026
Exhibit
99.1
Results of General Meeting
Sydney,
Australia – Friday, 11 September 2026 – Radiopharm Theranostics Limited
(ASX: RAD; Nasdaq: RADX) advises that all resolutions considered at the General Meeting held today were carried by poll.
In accordance with ASX Listing Rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.
Amritha
Sushil
Joint
Company Secretary
Radiopharm
Theranostics Limited
Suite
1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia
ABN:
57 647 877 889
In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.²³